Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Rosacea

- PMLiVE

Galderma’s nemolizumab shows promise in phase 3 prurigo nodularis trial

The condition affects more than 70 out of every 100,000 adults aged 18 to 64 years in the US

- PMLiVE

Galderma launches Rosacea Space to raise awareness

The platform invites people to share their experiences and what rosacea means to them

- PMLiVE

Galderma unites rosacea sufferers from around the globe in an empowering social media awareness movement: #RosaceaUnmasked

Rosacea is a skin disease that affects an estimated 415 million people worldwide

- PMLiVE

Galderma launches Rosacea awareness campaign

Campaign comes on the back of Rosacea Awareness Month

- PMLiVE

Almirall launches story campaign to raise rosacea awareness

The Red Girl highlights the negative psychological effects of the disease

- PMLiVE

Galderma removed from list of companies compliant to UK Code

Follows breach of pharma standards

- PMLiVE

Bayer sues Glenmark over its skin disorder generic

India-based firm files for US approval of its version of Finacea

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links